Fungemia due to rare non-Candida yeasts between 2018 and 2021 in a Greek tertiary care university hospital.

[1]  J. F. Höfling,et al.  Antibiofilm and Anti-Candidal Activities of the Extract of the Marine Sponge Agelas dispar , 2021, Mycopathologia.

[2]  T. Efferth,et al.  Fungal Biofilms as a Valuable Target for the Discovery of Natural Products That Cope with the Resistance of Medically Important Fungi—Latest Findings , 2021, Antibiotics.

[3]  D. Seidel,et al.  All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections , 2021, mBio.

[4]  J. Perfect,et al.  Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. , 2021, The Lancet. Infectious diseases.

[5]  M. Jacquet,et al.  MALDI-TOF MS in a Medical Mycology Laboratory: On Stage and Backstage , 2021, Microorganisms.

[6]  P. Pappas,et al.  Candidemia and Invasive Candidiasis. , 2021, Infectious disease clinics of North America.

[7]  Bing Chen,et al.  Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation , 2020, JAMA network open.

[8]  S. Ranque,et al.  Optimization of MALDI-ToF mass spectrometry for yeast identification: a multicenter study. , 2020, Medical mycology.

[9]  J. C. Junqueira,et al.  Candida Biofilms: An Update on Developmental Mechanisms and Therapeutic Challenges , 2020, Mycopathologia.

[10]  M. Akova,et al.  Fungaemia due to rare yeasts in a tertiary care university centre within 18 years , 2020, Mycoses.

[11]  G. Dimitriou,et al.  SACCHAROMYCES CEREVISIAE FUNGAEMIA IN AN IMMUNOCOMPETENT TODDLER , 2020, Journal of Paediatrics and Child Health.

[12]  I. Ramírez,et al.  Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp. , 2019, Mycopathologia.

[13]  P. Ravazoula,et al.  Cryptococcus gattii infection in an immunocompetent host in Greece , 2019, Medical mycology case reports.

[14]  A. Colombo,et al.  Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  T. Walsh,et al.  The expanding use of matrix-assisted laser desorption/ionization-time of flight mass spectroscopy in the diagnosis of patients with mycotic diseases , 2019, Expert review of molecular diagnostics.

[16]  Yee-Chun Chen,et al.  The epidemiology of non‐Candida yeast isolated from blood: The Asia Surveillance Study , 2018, Mycoses.

[17]  M. Aydoğdu,et al.  Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient. , 2017, Journal de mycologie medicale.

[18]  J. Guinea,et al.  Fungemia due to rare opportunistic yeasts: data from a population‐based surveillance in Spain , 2017, Medical mycology.

[19]  S. Ranque,et al.  Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin. , 2016, FEMS Yeast Research.

[20]  M. Cogliati,et al.  Cryptococcus gattii sero-mating type allelic pattern determined by multiplex PCR. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  J. Meis,et al.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  H. Schønheyder,et al.  Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[23]  W. Liao,et al.  Rapid Differentiation of Cryptic Species within Cryptococcus gattii by a Duplex PCR Assay , 2013, Journal of Clinical Microbiology.

[24]  C. Burgaleta,et al.  Epidemiology and outcome of Rhodotorula infection in haematological patients , 2011, Mycoses.

[25]  T. G. Mitchell,et al.  Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. , 2009, Medical mycology.

[26]  H. Ostermann,et al.  Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[27]  S. Stepanović,et al.  Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[28]  B. Arthington-Skaggs,et al.  Paradoxical Growth Effect of Caspofungin Observed on Biofilms and Planktonic Cells of Five Different Candida Species , 2007, Antimicrobial Agents and Chemotherapy.

[29]  M. Pfaller,et al.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing , 2007, Journal of Clinical Microbiology.

[30]  M. Cogliati,et al.  Determination of Cryptococcus neoformans var. neoformans mating type by multiplex PCR. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  M. Ghannoum,et al.  Biofilms and beyond: expanding echinocandin utility. , 2018, The Journal of antimicrobial chemotherapy.

[32]  B. P. Krom,et al.  In Vitro Models for Candida Biofilm Development. , 2016, Methods in molecular biology.

[33]  M. J. Mendes-Giannini,et al.  Highlights in pathogenic fungal biofilms. , 2014, Revista iberoamericana de micologia.

[34]  Russell E. Lewis,et al.  Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. , 2012, The Journal of infection.

[35]  M. Cogliati,et al.  Genotyping Cryptococcus neoformans var. neoformans with specific primers designed from PCR-fingerprinting bands sequenced using a modified PCR-based strategy. , 2000, Medical mycology.